Cytomegalovirus infection and cardiac allograft vasculopathy in children.
Webber
Steven A
SA
D000914:Antibodies, Viral / Q000097:blood; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D003327:Coronary Disease / Q000209:etiology* / Q000517:prevention & control; D003587:Cytomegalovirus / Q000276:immunology / Q000472:pathogenicity; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000517:prevention & control; D005500:Follow-Up Studies; D006085:Graft Survival; D016027:Heart Transplantation; D006801:Humans; D011183:Postoperative Complications / Q000209:etiology* / Q000517:prevention & control / Q000821:virology; D011292:Premedication; D012189:Retrospective Studies; D012307:Risk Factors; D018401:Sample Size; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014777:Virus Diseases / Q000150:complications; D017735:Virus Latency
D000914:Antibodies, Viral; D000998:Antiviral Agents